Molecular research allowed us to distinguish a new group of ALL, Ph-like ALL, which is characterized by broad-spectrum genetic alterations, but does not have an exact BCRL/ABL1 fusion. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.